Mayo Clinic

At TripleBlind, we offer digital privacy as a service. Our suite of tools enables companies to safely provide and consume extremely sensitive data and algorithms in encrypted space, in the most private and secure setting that has ever existed.

Marigold Health uses AI-augmented chat support groups to reach and retain patients with behavioral health needs in community-based treatment. Patients receive a personalized wraparound support while care teams see dramatic gains in capacity using patients to engage each other. We partner directly with treatment providers and managed care organizations in the Medicaid market.

SimBioSys, Inc. is developing a Computational Microscope that integrates state-of-the-art simulation techniques with a diverse set of experimental datasets to provide new insight into the behavior of cancers. The technology allows researchers to peer into the cancer microenvironment to identify the behavior of tumors: the cell phenotypes, how they interact with surrounding tissues, and how they prime their neighbors for invasion, all from the comfort of their computer desk.

Theator Inc. develops a personalized and artificial intelligence (AI) powered, surgeon growth video platform. The company offers Minutes, which is based on a real-world dataset and comprised of two general modules for surgeons, including content management software and a visual operative report with analytics. Further, it houses and analyzes video data from surgical procedures and is intended to be utilized by surgeons to review and analyze prior surgeries for educational purposes. Theator Inc. was incorporated in 2018 and is based in San Mateo, California.

Tympany is a platform for performing minimally invasive ear surgeries, reducing unnecessary mastoidectomys and improving outcomes.

MediView, LLC, a medical device company, develops an augmented reality surgical navigation system to improve surgical process for surgeons. It offers MediView, a product that is used in surgical navigation with intended use in ablation and biopsy of cancerous tumors. MediView, LLC was founded in 2017 and is based in Cleveland, Ohio.

GYANT.com, Inc. develops artificial intelligence (AI) based chatbot application that connects physicians and patients. It offers GYANT, a platform that enables physicians to help patients with diagnosis, prescriptions, and treatment recommendations. The company enables to emit a first diagnostic after asking a few questions and helps and diagnoses people suffering from diseases. It serves hospitals, health systems, integrated delivery networks, and providers. GYANT.com, Inc. was incorporated in 2016 and is based in Corte Madera, California.

Anexon, Inc., a pharmaceutical company, develops therapeutics for cardiovascular diseases. The company is based in Cambridge, Massachusetts.

Rheostat’s mission is to invent novel treatments for neurodegenerative disease through modulation of mitophagy and autophagy. They believe that the degradation of toxic cellular components, whether they are damaged organelles or aggregated proteins, is a fundamental node of biology. Mutations that impair these clearance pathways cause multiple neurodegenerative diseases, many of which are associated with cognitive impairment. They aim to leverage our understanding of these critical pathways to discover and develop novel small molecules that will restore cellular balance and treat neurodegenerative and rare diseases.

The Safely App lets potential partners share their verified STD and COVID status in a way that's trusted, private, and secure. More than an app, Safely is a movement to disrupt the spread of STD's and make the world a safer (and more fun) place to be. Behind it's sexy exterior, Safely is a fully vertically integrated healthcare company with partnerships and proprietary integrations with many of the world's leading healthcare companies, including Quest, Labcorp Mayo Clinic, EPIC, CVS, and more. SAFE works in partnership with the CDC, many of the world's top nonprofit organizations and influencers, plus social media platforms and dating apps, to empower this and future generations to know and show their status.

Theator Inc. develops a personalized and artificial intelligence (AI) powered, surgeon growth video platform. The company offers Minutes, which is based on a real-world dataset and comprised of two general modules for surgeons, including content management software and a visual operative report with analytics. Further, it houses and analyzes video data from surgical procedures and is intended to be utilized by surgeons to review and analyze prior surgeries for educational purposes. Theator Inc. was incorporated in 2018 and is based in San Mateo, California.

NewCompliance Group B.V. develops and delivers dashboards that provide insights and improves the safety and efficiency in hospitals during the entire surgical process. It offers Operating Room Cockpit system that integrates and draws data from EMR, building, and other operating room (OR) equipment. The company’s OR Cockpit tracks, validates, and interprets data and display essential information needed by clinical staff during procedures. It also provides OR Financial that OR managers and hospital executives detailed and complete insight into the cost of individual surgeries by bringing together existing data; and OR Analytics platform that draws data from the EMR, facilities, and other major OR equipment to allow the user to design any type of combined and visual analysis in real-time. The company serves customers in Europe and the United States. The company was founded in 2006 and is based in The Hague, the Netherlands with additional offices in Nijmegen, the Netherlands; San Rafael, California; and Houston, Texas.

Hui-Gene Therapeutics Co., Ltd. engages in the research and development of single-gene disorders. It also develops pilot pipes in neurodegenerative diseases, vision disorders, and others. The company was founded in 2018 and is based in Shanghai, China.

Medically Home is a tech-enabled clinical enterprise that provides all the necessary capabilities to safely-shift medical care from hospitals to patients’ homes. The company's virtual hospital model brings the hospital to patient's homes currently, the model is in service in eastern Massachusetts serving patients diagnosed with high acuity conditions including heart failure, pneumonia, urinary tract infections, cellulitis or wound infection, COPD or asthma exacerbation, and sepsis/fever. The company was founded in 2016 and is headquartered in Boston, Massachusetts.

Vyriad is a clinical-stage company developing proprietary oncolytic virus therapies for the treatment of cancers with significant unmet needs. The potentially life-changing oncolytic viral technologies of Vyriad are the result of decades of research by dedicated researchers and clinicians at Mayo Clinic and the University of Miami.

Stride Health, Inc. operates a health benefits platform that allows independent workers and part-time employees to select and enroll in affordable health coverage. It offers dental plans, drive plans, and doctor and prescription insurance plans. The company serves customers in the United States. Stride Health, Inc. was formerly known as Covered, Inc. and changed its name to Stride Health, Inc. in March 2013. The company was incorporated in 2013 and is based in San Francisco, California.

Helixis, Inc. is a company that develops low-cost molecular diagnostic products.

Ambient Clinical Analytics is the creator of a software platform designed for data assimilation, communication and analytics. It is based on decision support tools initially deployed in the intensive care unit (ICU) or emergency department of hospitals. Our software consists of algorithms that mine data from electronic medical records (EMR). It then presents that data to the physicians and nurses so they may facilitate real-time clinical decision making and care delivery. These products are positioned as add on applications that are designed to easily integrate with the current major EMR providers.

Adaptive Phage Therapeutics, Inc. offers therapeutic solutions for the global rise of multi-drug resistant (MDR) pathogenic bacteria. The company offers PhageBank, a large and dynamically growing collection of bacteriophages or phages (viruses that attack specific targeted bacteria) and a rapid system for matching phage to patient-specific bacterial infections. The company was founded in 2016 and is headquartered in Gaithersburg, Maryland.

Unity Biotechnology designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells; and designs senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected.

Medically Home is a tech-enabled clinical enterprise that provides all the necessary capabilities to safely-shift medical care from hospitals to patients’ homes. The company's virtual hospital model brings the hospital to patient's homes currently, the model is in service in eastern Massachusetts serving patients diagnosed with high acuity conditions including heart failure, pneumonia, urinary tract infections, cellulitis or wound infection, COPD or asthma exacerbation, and sepsis/fever. The company was founded in 2016 and is headquartered in Boston, Massachusetts.

Pendulum Therapeutics Inc., a microbiome company, produces microbiome-targeted medical probiotics. It offers Pendulum Glucose Control, a medical probiotic for the dietary management of type 2 diabetes. The company also develops prebiotics to help feed the probiotic strains. It sells its products online. Pendulum Therapeutics Inc. was formerly known as Whole Biome Inc. and changed its name to Pendulum Therapeutics Inc. in July 2019. The company was incorporated in 2012 and is based in San Francisco, California.

Diagnostic Robotic develops a signal-agnostic artificial intelligence system for healthcare insurers, providers, and patients. It allows to build powerful predictive analytics models that will solve a world-wide challenge, strained health budgets, and workforces. Diagnostic Robotic was founded on 2017 and is headquartered in Tel Aviv, Israel.

CloudPost Networks Inc. develops Internet of things (IoT) security and risk-reduction solutions that protect business-critical devices and systems. The company ties device identity with behavioral analytics so organizations can spot security issues and implements precise controls to protect the environment. CloudPost Networks Inc. was incorporated in 2015 and is based in Santa Clara, California.

Laplace developing Transcatheter Tricuspid Valve Technology to offer an increase in life expectancy and an improvement to the quality of life to worldwide patients with tricuspid regurgitation.

Karkinos Healthcare is technology-driven oncology focussed managed health care platform for the early detection and diagnosis of common cancers.

Ambient Clinical Analytics is the creator of a software platform designed for data assimilation, communication and analytics. It is based on decision support tools initially deployed in the intensive care unit (ICU) or emergency department of hospitals. Our software consists of algorithms that mine data from electronic medical records (EMR). It then presents that data to the physicians and nurses so they may facilitate real-time clinical decision making and care delivery. These products are positioned as add on applications that are designed to easily integrate with the current major EMR providers.

Qrativ is a developer of a drug purposing platform designed to reinvent the way treatments for diseases with unmet medical need are discovered and developed. The company's platform ,Darwin.ai, identifies new uses for existing molecules for diseases with unmet medical need and uses machine learning and artificial intelligence for research and development, enabling patient to get treatments for diseases for which drugs are not available in the market.

Torax Medical, Inc. develops and markets products/devices to restore the barrier function of sphincters. The company’s products include LINX, a reflux management system to treat patients diagnosed with gastroesophageal reflux disease; and FENIX, a continence restoration system for the treatment of fecal incontinence. It sells its products in Europe and the United States. Torax Medical, Inc. was founded in 2002 and is based in Shoreview, Minnesota. As of March 23, 2017, Torax Medical, Inc. operates as a subsidiary of Ethicon, Inc.

Senda Biosciences is pioneering the field of Intersystems Biology to create novel treatments for human disease. Intersystems Biology focuses on how molecular connections between botanical, bacterial, and human cells—coevolved over millennia—define health and disease. Senda's Intersytems Biology discovery platform, built using new techniques in machine learning and computational biology, has been able to generate novel, actionable insights into the trillions of interspecies molecular connections in the human body, and harnesses the power of this "pharmacy within us" with novel pharmacological approaches. The power of the Senda platform is illustrated by six preclinical programs in oncology, neurology, chronic disease, and metabolic disease.

Helix is the leading population genomics company working at the intersection of clinical care, research, and genomics. Its end-to-end platform enables health systems, life sciences companies, and payers to advance genomic research and accelerate the integration of genomic data into clinical care. Powered by one of the world's largest CLIA / CAP next-generation sequencing labs and its proprietary Exome+™ assay, Helix supports all aspects of population genomics including recruitment and engagement, clinically actionable disease screening, return of results, and basic and translational research.

Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. The Senza system is the only SCS system that delivers Nevro's proprietary HF10 therapy. Senza, HF10, Nevro and the Nevro logo are trademarks of Nevro.

FundamentalVR have been working with leading pharmaceutical companies to combine virtual and mixed reality with haptic feedback using their ‘FeelRealVR’ platform to create simulated surgical procedures to help educate and train healthcare professionals.

Glooko is the universal diabetes platform that provides insights to improve outcomes for people with diabetes (PWDs) and their care teams. Glooko connects to the world’s most popular diabetes devices, major fitness and activity trackers and supplies personalized, timely patient information such as glucose level, food, insulin, medications, blood pressure, diet and weight data. Trusted by the world’s leaders in diabetes care, we are in over 7,000 clinical locations and used by over 1.5 million PWDs in 23 countries across 15 languages. Learn more by visiting www.glooko.com.

At TripleBlind, we offer digital privacy as a service. Our suite of tools enables companies to safely provide and consume extremely sensitive data and algorithms in encrypted space, in the most private and secure setting that has ever existed.

Torax Medical, Inc. develops and markets products/devices to restore the barrier function of sphincters. The company’s products include LINX, a reflux management system to treat patients diagnosed with gastroesophageal reflux disease; and FENIX, a continence restoration system for the treatment of fecal incontinence. It sells its products in Europe and the United States. Torax Medical, Inc. was founded in 2002 and is based in Shoreview, Minnesota. As of March 23, 2017, Torax Medical, Inc. operates as a subsidiary of Ethicon, Inc.

Nuvolo Technologies Corporation provides a cloud-based enterprise asset management platform under the name ServiceNow. The company provides life-cycle management solutions for enterprise assets of clinics, laboratories, facilities, and manufacturers. Additionally, it offers implementation, support, tracking, reporting, and analytics solutions. The company has strategic partnerships with Atos, Fruition Partners, InSource, KPMG, and Unisys. Nuvolo Technologies Corporation was founded in 2013 and is based in Paramus, New Jersey with additional offices in London, United Kingdom; Sofia, Bulgaria; and Pune, India.

StemoniX Inc. provides IPS-based platforms for pharma and research institutions. The company offers StemoniX, a platform that focuses on printing of stem-cell derived human tissue for custom drug discovery and personalized medicine. Its solution enables scaled 3-D printing of living cells into larger form factors for heart disease, dementia, breast cancer, autism, ALS, and more. The company was incorporated in 2014 and is headquartered in Minneapolis, Minnesota with an additional office in LA Jolla, California.

Nference AI technology enables knowledge synthesis from unstructured text and structured biomedical databases. It synthesizes exponentially growing biomedical knowledge to solve urgent healthcare problems. The company uses state-of-the-art neural networks for real-time, automated extraction of insights by triangulating unstructured and structured information from the biomedical literature as well as from large scale molecular and real-world datasets. The platform enables a diverse set of applications ranging from R&D to commercial strategy and operations in the life sciences ecosystem. Nference was founded in 2015 and is headquartered in Cambridge, Massachusetts.

Geneticure Inc., a pharmacogentic testing company, develops and researches in tests that clinicians use to provide personalized medicine. It develops Geneticure, a prescription drug process that includes DNA extraction and genotyping followed by the provision of genetic results directly to the doctor, along with a summary for each gene and a decision tree of most to least functional genes and optimization of blood pressure therapy utilizing the information by the clinician. The company offers unique genetic information to healthcare providers that determine the right course of treatment for patients suffering from hypertension. Geneticure Inc. was founded in 2012 and is based in Eden Prairie, Minnesota.

Adaptive Phage Therapeutics, Inc. offers therapeutic solutions for the global rise of multi-drug resistant (MDR) pathogenic bacteria. The company offers PhageBank, a large and dynamically growing collection of bacteriophages or phages (viruses that attack specific targeted bacteria) and a rapid system for matching phage to patient-specific bacterial infections. The company was founded in 2016 and is headquartered in Gaithersburg, Maryland.

Sensely is a developer of avatar and chatbot-based platform designed to assist insurance plan members and patients. The company's platform leverages conversational interfaces and provides virtual assistant solutions to insurance companies, pharmaceutical clients, and hospital systems worldwide, enabling enterprises to converse with their members in an entirely new way, combining the empathy of human conversation with the efficiency and scalability of the technology.

NBI Development is an implantable medical device company focused on the development of novel neuromodulation therapies. The company develops Neuromodulation, the use of electrical impulses to manage activity in the nervous system.

Glooko is the universal diabetes platform that provides insights to improve outcomes for people with diabetes (PWDs) and their care teams. Glooko connects to the world’s most popular diabetes devices, major fitness and activity trackers and supplies personalized, timely patient information such as glucose level, food, insulin, medications, blood pressure, diet and weight data. Trusted by the world’s leaders in diabetes care, we are in over 7,000 clinical locations and used by over 1.5 million PWDs in 23 countries across 15 languages. Learn more by visiting www.glooko.com.

Second Genome’s mission is to transform lives with medicines developed through innovative microbiome science. Second Genome has built a novel platform for microbiome drug discovery. Second Genome has completed more than 400 microbiome studies, analyzing more than 75,000 samples, for internal R&D, as well as for external partners across government, academia, pharmaceutical, nutrition and industrial companies. The team leverages its microbiome analysis platform with its partners’ specific expertise to generate insightful findings that can accelerate research programs by elucidating the role of the microbiome in human health conditions, agriculture, animal health and other industries. The company has established a pipeline of therapeutic products for the treatment of inflammation and metabolic diseases.

Vineti is a commercial cloud-based platform that expands patient access to life-saving cells and gene therapies. The software solution offers an independent, purpose-built enterprise solution that is essential for enabling the growth and wide distribution of transformative personalized therapeutics, such as CAR-T cell therapies, for the treatment of late-stage cancer. The Vineti Personalized Therapy Management (PTM) ® platform automates patient-centric supply chains for a wide range of advanced therapies, in all phases of clinical development and commercial operations. Veneti aims to solve the key challenges patients, medical providers, pharmaceutical companies, and regulators face in the delivery and commercialization of personalized medicine. Amy DuRoss, Heidi M. Hagen, Malek Faham, Razmik Abnous, and Stephen Ting co-founded Vineti in San Francisco, California in 2016.

Naviscan, Inc. is the leader in organ-specific molecular imaging. The company designs, manufactures, and distributes a high-resolution PET scanner which provides unprecedented visualization of small body parts. While Naviscan’s PET scanner can image virtually any body part that can fit into the gantry, it is most often utilized as an adjunct to conventional imaging technologies by clinicians who stage and manage breast cancer. Surgeons, radiologists, nuclear physicians, and oncologists in hospitals and breast clinics use our compact, mobile and easy-to-use PET scanner to precisely characterize breast cancer, enhance surgical planning, monitor patient response to therapy, and evaluate suspected recurrence.

Vineti is a commercial cloud-based platform that expands patient access to life-saving cells and gene therapies. The software solution offers an independent, purpose-built enterprise solution that is essential for enabling the growth and wide distribution of transformative personalized therapeutics, such as CAR-T cell therapies, for the treatment of late-stage cancer. The Vineti Personalized Therapy Management (PTM) ® platform automates patient-centric supply chains for a wide range of advanced therapies, in all phases of clinical development and commercial operations. Veneti aims to solve the key challenges patients, medical providers, pharmaceutical companies, and regulators face in the delivery and commercialization of personalized medicine. Amy DuRoss, Heidi M. Hagen, Malek Faham, Razmik Abnous, and Stephen Ting co-founded Vineti in San Francisco, California in 2016.

Qlaris Bio, Inc., a biotechnology company, develops therapies for debilitating ophthalmic diseases. It offers QLS-101, a therapy to reduce intraocular pressure. Qlaris Bio, Inc. was founded in 2017 and is headquartered in Wellesley, Massachusetts.

AliveCor has a device and application that will turn any smartphone into a clinical-quality electrocardiogram (ECG) recorder. AliveCor is pioneering the creation of FDA-cleared 'machine learning' techniques to enable proactive heart care and is recognized around the world for transforming cardiac care. It specializes in the fields of healthcare, mobile device, and medicine. It was founded in 2010 and headquartered in Mountain View, California.

Elysium Health offers health products built with science such as dietary supplements and anti-aging drugs. It seeks to solve challenges in health with science, to help people live healthier and longer lives. It works directly with the scientists, clinicians, and health professionals around the world to identify and develop the natural compounds. Its product is a proprietary formulation of two ingredients designed to support long-term well-being at the cellular level.

Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. The Senza system is the only SCS system that delivers Nevro's proprietary HF10 therapy. Senza, HF10, Nevro and the Nevro logo are trademarks of Nevro.

Eko harnesses the power of smartphones and cloud data for monitoring patients with cardiovascular diseases. It has built a platform of non-invasive cardiovascular monitoring devices, clinical software, and point-of-care decision support algorithms to improve the delivery of cardiovascular care. In 2015, Eko launched the Eko Core Digital Stethoscope, the first FDA-cleared digital stethoscope on the market to wirelessly stream heart and lung sound to HIPAA-compliant software. For the first time in history, patient sounds can be integrated with electronic health records (EHRs) for more seamless referrals, documentation, and monitoring. Eko was established in 2013 and is based in Berkeley, California.

Better provides symptom advice and the clinic's health database free of charge. The company helps collect all health records from various doctors and provide round-the-clock access to health-care workers who can help navigate insurance claims or advise on setting up appointments. The company was founded in 2013 and is based in Palo Alto, California.

Chrono Therapeutics Inc., a digital transdermal drug delivery company, develops SmartStop, a digital nicotine replacement therapy. Its wearable solution tailors the timing and dose sizes of drugs, preempts predictable peak disease, and addiction symptoms with a device. The company was incorporated in 2003 and is based in Hayward, California.

Torax Medical, Inc. develops and markets products/devices to restore the barrier function of sphincters. The company’s products include LINX, a reflux management system to treat patients diagnosed with gastroesophageal reflux disease; and FENIX, a continence restoration system for the treatment of fecal incontinence. It sells its products in Europe and the United States. Torax Medical, Inc. was founded in 2002 and is based in Shoreview, Minnesota. As of March 23, 2017, Torax Medical, Inc. operates as a subsidiary of Ethicon, Inc.

Kardia Health Systems is a healthcare information technology firm offering the delivery of specialty medicine, starting with cardiology. Using Internet technology and a Software-as-a-Service (SaaS) business model, Kardia makes this technology accessible to practices of varying sizes. Kardia Health Systems, Inc. was incorporated in 2006 and is based in Golden Valley, Minnesota.

Ambra Health is a medical data and image management SaaS company. Intuitive, flexible, scalable and highly interoperable, the Ambra cloud platform is designed to serve as the backbone of imaging innovation and progress for healthcare providers. It empowers some of the largest health systems such as Memorial Hermann, Stanford Children’s Health and New England Baptist Hospital as well as radiology practices, subspecialty practices and clinical research organizations to dramatically improve imaging and collaborative care workflows. As expert partners, we listen to our customers, understand their needs, and apply our extensive knowledge to deliver innovative medical image management solutions for the future of healthcare, now.

Chrono Therapeutics Inc., a digital transdermal drug delivery company, develops SmartStop, a digital nicotine replacement therapy. Its wearable solution tailors the timing and dose sizes of drugs, preempts predictable peak disease, and addiction symptoms with a device. The company was incorporated in 2003 and is based in Hayward, California.

Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. The Senza system is the only SCS system that delivers Nevro's proprietary HF10 therapy. Senza, HF10, Nevro and the Nevro logo are trademarks of Nevro.

Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. The Senza system is the only SCS system that delivers Nevro's proprietary HF10 therapy. Senza, HF10, Nevro and the Nevro logo are trademarks of Nevro.

Nference AI technology enables knowledge synthesis from unstructured text and structured biomedical databases. It synthesizes exponentially growing biomedical knowledge to solve urgent healthcare problems. The company uses state-of-the-art neural networks for real-time, automated extraction of insights by triangulating unstructured and structured information from the biomedical literature as well as from large scale molecular and real-world datasets. The platform enables a diverse set of applications ranging from R&D to commercial strategy and operations in the life sciences ecosystem. Nference was founded in 2015 and is headquartered in Cambridge, Massachusetts.

Assurex Health is a personalized medicine company dedicated to helping clinicians determine the right medication for individual patients with medical conditions. Assurex Health’s proprietary Genesight® technology is based on pharmacogenomics – the study of the genetic factors that influence an individual’s response to drug treatments – as well as evidence-based medicine and clinical pharmacology.

Cadence Neuroscience is an early-stage company developing new medical device therapies for the treatment of epilepsy, central pain, and other neurological disorders. The company's core technology has been developed at Mayo Clinic and is under clinical evaluation. Its medical device therapies provide medical practitioners with the procedure that can be used to tailor brain stimulation therapy to each individual and enhance seizure control compared to currently used protocols. Cadence Neuroscience was established in 2017 and is headquartered in Redmond, Washington.

Securisyn Medical is an innovative medical technology and solutions company dedicated to enhancing ventilated patient safety, preventing unplanned extubation and its associated complications, providing peace of mind for patients, their families, and practitioners, and decreasing healthcare costs through ethical, profitable, and sustainable business practices. The company is focused on collaborating with stakeholders around the world to eliminate preventable deaths related to airway management.

Progentec Diagnostics, Inc. develops a diagnostic test. It offers aiSLE DX, a platform that provides tests to help patients and their providers in managing the disease. The company’s tests include a flare prediction score, a reliable metric to proactively measure disease activity in SLE patients, and an early lupus diagnosis test. Progentec Diagnostics, Inc. was incorporated in 2015 and is headquartered in Oklahoma City, Oklahoma.

Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a monoclonal microbial candidate, which is in Phase 1b placebo-controlled dose-escalating safety and tolerability clinical study for the treatment of psoriasis or atopic dermatitis. The company is also developing monoclonal microbial candidates, which are in pre-clinical development stage include EDP1815 for treating psoriatic arthritis, rheumatoid arthritis, and axial spondyloarthritis; EDP1867 for asthma; EDP2939 for inflammatory disease; and EDP1632 for neuro-inflammatory diseases. In addition, it is developing EDP1503, a monoclonal microbial candidate, which is in Phase 1/2 clinical study for the treatment of colorectal cancer, triple-negative breast cancer, and melanoma, as well as patients who have relapsed on prior PD-1/L1 inhibitor treatment. The company was founded in 2014 and is headquartered in Cambridge, Massachusetts.

Lifecode, Inc. operates as a next-generation-sequencing (NGS) based molecular diagnostics company. It develops a portfolio of NGS-based cancer assays, including the pan cancer somatic panel for use across metastatic cancer, rare and refractory cancers, standard of care exhausted, and patients looking for a clinical trial. The company also provides clinical information designed to help physicians make treatment decisions for their patients. Lifecode, Inc. was formerly known as Silicon Valley Biosystems, Inc. and changed its name to Lifecode, Inc. in January 2015. The company was incorporated in 2011 and is based in Foster City, California. As of February 24, 2016, Lifecode, Inc. operates as a subsidiary of MedGenome Labs Private Ltd.

Unity Biotechnology designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells; and designs senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected.

The pendulum is the microbial company to apply the discoveries of high-resolution, long-read DNA sequencing to the development of microbiome interventions targeting specific diseases. With a team of accomplished scientists, clinicians, engineers and innovators committed to Its mission of making millions healthier through microbiome-targeted medical probiotics.

GIBLIB is a California-based company and is the "Netflix" of Medical Education. It is a place for surgeons to share medical lectures and surgical videos. Founded in 2015, GIBLIB is headquartered in Los Angeles, California.

Sanguine develops innovative technology solutions for clinical researchers. The company facilitates clinical trials by recruiting participants, conducting at-home data collection, and processing samples, enabling clinicians to prescribe the right medicines.

DayTwo Ltd. develops and operates a web-based platform that provides actionable health improvement and disease prevention solutions based on gut microbiome. The company's products include additional microbiome based diagnostic and therapeutic solutions. It also provides its services through a smart phone application. The company was founded in 2015 and is headquartered in Tel Aviv-Yafo, Israel.

Seres Health is a clinical-stage therapeutics company focused on discovering and developing drugs to treat diseases of the microbiome. The biology of the microbiome is driven by ecologies—the functional collections of various organisms—which are central to health and disease. Seres is developing Ecobiotic™ therapeutics to treat diseases that have an underlying microbiome biology. Our first clinical program is in the treatment of Clostridium difficile infection.

KitCheck is a provider of a cloud software platform used to offer automated hospital pharmacy kit processing and medication tracking. The company provides cloud-hosted software combined with IoT technology to reduce kit replenishment time by 72-96% while simultaneously delivering higher accuracy and eliminating errors. In addition, the Narc Check product streamlines recording, waste reconciliation, and billing for medications used in the operating room. Kit Check is used across hundreds of hospitals in the U.S. and Canada and tracks over 90% of all kit medication volume in the industry that is digitally tracked.

Cardero Therapeutics is a start-up pharmaceutical company that is developing a novel class of therapeutics that induces the formation of new mitochondria (mitochondrial biogenesis) and enhances mitochondrial function in response to metabolic demand. Chronic depletion of mitochondria, the principal source of cellular ATP, has been directly linked to the progression of heart failure, sarcopenia, and neurodegeneration. Cardero Therapeutics is collaborating with numerous academic medical centers to advance novel drug candidates structurally based on a newly discovered human hormone that appears to fundamentally regulate mitochondrial density and function in all tissues. Cardero Therapeutics believes that enhancing myocyte bioenergetics will comprise an innovative therapeutic approach complementary to currently available cardiovascular drugs. The company’s clinical development focus is the lethal cardiomyopathy associated with orphan diseases characterized by loss of mitochondria in muscle and heart, resulting in heart failure that is poorly responsive to current medical interventions. Initial clinical trials are directed toward Duchenne muscular dystrophy and Friedreich’s ataxia.

Helix is the leading population genomics company working at the intersection of clinical care, research, and genomics. Its end-to-end platform enables health systems, life sciences companies, and payers to advance genomic research and accelerate the integration of genomic data into clinical care. Powered by one of the world's largest CLIA / CAP next-generation sequencing labs and its proprietary Exome+™ assay, Helix supports all aspects of population genomics including recruitment and engagement, clinically actionable disease screening, return of results, and basic and translational research.

Torax Medical, Inc. develops and markets products/devices to restore the barrier function of sphincters. The company’s products include LINX, a reflux management system to treat patients diagnosed with gastroesophageal reflux disease; and FENIX, a continence restoration system for the treatment of fecal incontinence. It sells its products in Europe and the United States. Torax Medical, Inc. was founded in 2002 and is based in Shoreview, Minnesota. As of March 23, 2017, Torax Medical, Inc. operates as a subsidiary of Ethicon, Inc.

Novome Biotechnologies, Inc. engineers and develops bacteria from the human gut to treat diseases. Its platform enables controllable engraftment of genetically engineered microbial medicines in the gut for sustained therapies. The company’s synthetic biology tools allow to plug into ecosystem and deliver precise activities to treat chronic diseases. Novome Biotechnologies, Inc. was incorporated in 2015 and is based in South San Francisco, California.

Eko harnesses the power of smartphones and cloud data for monitoring patients with cardiovascular diseases. It has built a platform of non-invasive cardiovascular monitoring devices, clinical software, and point-of-care decision support algorithms to improve the delivery of cardiovascular care. In 2015, Eko launched the Eko Core Digital Stethoscope, the first FDA-cleared digital stethoscope on the market to wirelessly stream heart and lung sound to HIPAA-compliant software. For the first time in history, patient sounds can be integrated with electronic health records (EHRs) for more seamless referrals, documentation, and monitoring. Eko was established in 2013 and is based in Berkeley, California.

Ordr develops an AI-based systems control engine for the hyper-connected enterprise. Ordr's control engine is a purpose-built solution to fully map the device flow genome at massive scale, using machine learning to continuously inspect, classify, and baseline the behavior of every device. Its software architecture is unique in its ability to process enormous quantities of data in real-time, using AI to provide closed loop security, generating policies for each class of device and implementing those policies through the organization’s existing multi-vendor network and security infrastructure. Ordr was founded on 2015 and is headquartered in Santa Clara, California.

AtriAN is commercializing technology created at Mayo Clinic in the US. AtriAN is an Irish Medical Device company based in Galway--A powerful and prolific hub for medical devices.AtriAN uses a gentle energy, micro Pulsed Electric Fields (mPEF) to only ablate hyperactivity. The other tissues such as the myocardium are spared.

Kardia Health Systems is a healthcare information technology firm offering the delivery of specialty medicine, starting with cardiology. Using Internet technology and a Software-as-a-Service (SaaS) business model, Kardia makes this technology accessible to practices of varying sizes. Kardia Health Systems, Inc. was incorporated in 2006 and is based in Golden Valley, Minnesota.

The Kang San Global Medical Technology (Beijing) Co., Ltd. is a hi-tech enterprise of one for the country at all levels of the hospital to provide advanced specialist inspection services, and the establishment of the National Laboratory of Kang Sheng Global Medical Special Inspection Center. Of the center's national service network belongs wholly owned ...

Helix is the leading population genomics company working at the intersection of clinical care, research, and genomics. Its end-to-end platform enables health systems, life sciences companies, and payers to advance genomic research and accelerate the integration of genomic data into clinical care. Powered by one of the world's largest CLIA / CAP next-generation sequencing labs and its proprietary Exome+™ assay, Helix supports all aspects of population genomics including recruitment and engagement, clinically actionable disease screening, return of results, and basic and translational research.

Unity Biotechnology designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells; and designs senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected.

Naviscan, Inc. is the leader in organ-specific molecular imaging. The company designs, manufactures, and distributes a high-resolution PET scanner which provides unprecedented visualization of small body parts. While Naviscan’s PET scanner can image virtually any body part that can fit into the gantry, it is most often utilized as an adjunct to conventional imaging technologies by clinicians who stage and manage breast cancer. Surgeons, radiologists, nuclear physicians, and oncologists in hospitals and breast clinics use our compact, mobile and easy-to-use PET scanner to precisely characterize breast cancer, enhance surgical planning, monitor patient response to therapy, and evaluate suspected recurrence.

Progentec Diagnostics, Inc. develops a diagnostic test. It offers aiSLE DX, a platform that provides tests to help patients and their providers in managing the disease. The company’s tests include a flare prediction score, a reliable metric to proactively measure disease activity in SLE patients, and an early lupus diagnosis test. Progentec Diagnostics, Inc. was incorporated in 2015 and is headquartered in Oklahoma City, Oklahoma.